Shares of Futura Medical plc (LON:FUM – Get Free Report) were up 15.7% on Thursday . The stock traded as high as GBX 1.44 and last traded at GBX 1.44. Approximately 366,663 shares traded hands during trading, a decline of 97% from the average daily volume of 10,885,366 shares. The stock had previously closed at GBX 1.25.
Futura Medical Stock Performance
The business’s 50 day moving average price is GBX 1.37 and its 200-day moving average price is GBX 5.49. The firm has a market capitalization of £7.26 million, a PE ratio of -0.60 and a beta of 1.25.
Insider Transactions at Futura Medical
In other Futura Medical news, insider Harmesh Suniara sold 4,441,678 shares of the company’s stock in a transaction on Thursday, November 13th. The stock was sold at an average price of GBX 2, for a total transaction of £88,833.56. 25.86% of the stock is currently owned by insiders.
About Futura Medical
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
Featured Stories
- Five stocks we like better than Futura Medical
- Why Trump and Musk suddenly care about Fort Knox
- Best $19 you’ll spend this year.
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A “Roaring 20’s” Crash Signal is Back, But Much Worse
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
